Podcast

Efficient Communication Reduces Regulatory Uncertainty

CDO Magazine Podcast Series

By Chris Houchin

Dr. Peter Marks, Director of the Center for Biologics Evaluation and Research (CBER), U.S. Food and Drug Administration (FDA), speaks with Chris Houchin, Partner at Guidehouse, in a video interview about leveraging AI at the agency, developments in data-driven healthcare, and improving communication regarding frontier topics like explainability, data integrity, bias, and data security.

Speaking about the FDA’s approach to leveraging AI, Marks says that the agency is open to the use of AI but according to best practices. The application is being seen across multiple areas, from manufacturing to post-market surveillance. He mentions that the agency is using AI in manufacturing particularly in the complex biologics product area which involves multiple critical quality attributes that need to be checked during manufacturing.

 

Watch the full video below.


Let Us Guide You

Guidehouse is a global advisory, technology, and managed services firm delivering value to commercial businesses and federal, state, and local governments. Serving industries focused on communities, energy, and infrastructure, healthcare, financial services, and defense and national security, we position clients for AI-led innovation, efficiency, and resilience.

Stay ahead of the curve with news, insights and updates from Guidehouse about issues relevant to your organization and its work.